Bioresorbable scaffold: new data, new hope?

Session comprising selected EuroPCR 2019 abstract submissions

Chairperson: B. Xu
Panellists: H. Nef, R. Waksman, N. West
SHOW MORE

Summary

Consult this session on bioresorbable scaffold (BRS) to learn about new data and clinical outcomes: FAMTOM II trial, BIOSOLVE-IV registry, and more!

Presentations available when logged in:

  • Outcomes after resorption of coronary BRS
  • BRS - A tale of 253 scaffolds from a single-centre review
  • FANTOM II trial: safety and performance study of the Fantom sirolimus-eluting bioresorbable coronary scaffold - First report: three-year clinical o...
  • Safety and performance of the resorbable magnesium scaffold, Magmaris in a real-world setting - First 800 subjects at 12-month follow-up of the BIO...
  • Safety and clinical performance of the drug-eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary...